Richard H. Douglas
DirectoratNovavax· In proxies 2023–2025
Richard H. Douglas sits on 2 public boards.
Experience
- NovavaxPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +16%
- Alderya Therapeutics, Inc. (Nasdaq: ALDX)Public company
- Director? – PresentNo stock prices for these years
- MaxCyte, Inc. (Nasdaq: MXCT)Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?